Table 4.
Drug Choices in Hypothetical Drug Placement Scenarios in the Pharmacy & Therapeutics Committee Surveya
| Lipid-lowering drugs, N (%) | PPI drugs, N (%) | |
|---|---|---|
| Hypothetical drug | ||
| Drug A (lowest net ingredient cost) | 23 (77) | 25 (83) |
| Drug B | 7 (23) | 5 (17) |
| Least expensive net ingredient drug available on preferred tiers | ||
| Not available | 14 (93) | 11 (73) |
| Available | 1 (7) | 4 (27) |
a
Only 15 of 23 formularies for fibrates and 15 of 25 formularies for PPIs could be examined for those who chose lowest net ingredient cost in the hypothetical scenario.
PPI indicates proton-pump inhibitor.